A call for more dermatologic input into chronic graft-vs-host disease clinical trials

Arch Dermatol. 2009 Mar;145(3):337-8. doi: 10.1001/archdermatol.2008.606.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Benzamides
  • Chronic Disease
  • Clinical Trials as Topic
  • Dermatology
  • Graft vs Host Disease / diagnosis*
  • Graft vs Host Disease / drug therapy
  • Humans
  • Imatinib Mesylate
  • Piperazines / therapeutic use
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrimidines / therapeutic use
  • Scleroderma, Localized / diagnosis
  • Scleroderma, Localized / drug therapy
  • Skin Diseases / diagnosis*
  • Skin Diseases / drug therapy

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate